Healthcare and Biotech Investing: Breakthroughs in the Treatment of Cancer at ASCO…Update-4….6/29-MRK!
Update-4...6/29....I'm back but I did not miss much in biotech trades, but a lot of "3 day wonders'" you know stocks that get momentum then quickly fade. The XBI is still holding above the $90 support level with a range of $89.13 to $94.88 closing Friday at $92.71 so nimble traders could have...
Large Cap Biopharmaceuticals: Updates on #ASCO24 Week…Update-2
Update-2 Biopharma rally moves to SMID caps as momentum picks up ADPT, NVAX, TWST etc XBI over $93. Large caps steady with REGN over $1000. POST ASCO large cap core portfolio picks: ABBV, AZN, LLY, MRK, REGN. VRTX. Pfizer had good results but the stock could not break $30 so my calls with...
Life Science Momentum Trades In a Volatile Market…Update-6…..Many big winners
Update: 6/7/24.,,Our model still looks good for experienced traders.Today for example GERON (GERN) soared 19% with approval of RYTELO for MDS associated anemia. We will summarize news from winning stocks over the weekend. XBI was weak today down about 1% to $91 handle. Strong jobs could mean...
Large Cap Biopharmaceuticals Performance…Update-3 #ASCO24 gains are ahead
UPDATE 3: Large cap biopharmas were strong on Friday in anticipation of #ASCO24 data. Company news to watch from data below:AZN, BMY, GILD, LLY, MRK, PFE,REGN and also ADPT, MRUS, NVS. REPL.. See updates all next week. Update-2 MAY 31,,,Biopharma stocks took a dip midweek during FED speak then...
SMID Life Science Trades that Picked Up MOMENTUM…Update-4…nothing
Update-4 5/23/24...XBI down 3% to $89 handle, rates up =risk off, But S&P hold 5200. NVDA rules nothing else in broad sell-off. Update-3 5/22...XBI is holding the $92 level and several SMID stocks show gains:ADPT, CRNX,CRSP, PACB, TXG. NTRA near 52 wet high of $110. NVAX up 13% to $16.84...